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Rictor, a Novel Binding Partner of mTOR, Defines
a Rapamycin-Insensitive and Raptor-Independent
Pathway that Regulates the Cytoskeleton
Peptide mass fingerprinting analysis using mass
spectrometry and mass spectrometric sequencing re-
vealed that p200 is novel and not in the databases of
full-length human proteins. We named the 200 kDa pro-
tein rictor for rapamycin-insensitive companion of mTOR.
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1275 York Avenue protein is not well conserved among eukaryotes. Rictor
shares regions of homology with several poorly charac-New York, New York 10021
terized proteins, including pianissimo from D. discoi-
dieum [4], STE20p from S. pombe [5], and AVO3p from
S. cerevisiae [6, 7]. Proteins of similar domain structureSummary
and conservation are also encoded in the A. gambiae
and D. melanogaster genomes, suggesting that otherThe mammalian TOR (mTOR) pathway integrates nu-
eukaryotes may have rictor-like proteins. These proteinstrient- and growth factor-derived signals to regulate
share a region of about 200 amino acids in length (Figuregrowth, the process whereby cells accumulate mass
1B, box 1) of 44% similarity (8% identity) as well asand increase in size. mTOR is a large protein kinase
several smaller conserved regions, including a repeatedand the target of rapamycin, an immunosuppressant
block of 20 amino acids (Figure 1B, box 5). Despite thesethat also blocks vessel restenosis and has potential
regions of similarity, both rictor and dRictor (rictor’santicancer applications. mTOR interacts with the rap-
likely Drosophila homolog) have long C-terminal exten-tor and GL proteins [1–3] to form a complex that is
sions without apparent conservation or similarity to otherthe target of rapamycin. Here, we demonstrate that
proteins. Pianissimo is implicated in cAMP-induced cellmTOR is also part of a distinct complex defined by the
migration [4], and recent work from the Hall group indi-novel protein rictor (rapamycin-insensitive companion
cates that in S. cerevisiae, AVO3p is part of a rapamycin-of mTOR). Rictor shares homology with the previously
insensitive TOR2p-containing complex that regulatesdescribed pianissimo from D. discoidieum [4], STE20p
the actin cytoskeleton [6]. In S. pombe, STE20p func-from S. pombe [5], and AVO3p from S. cerevisiae [6, 7].
tions in the cell cycle arrest induced by nutrient depriva-Interestingly, AVO3p is part of a rapamycin-insensitive
tion [5].TOR complex that does not contain the yeast homolog
Using a rictor antibody, we confirmed that rictor isof raptor and signals to the actin cytoskeleton through
part of the endogenous mTOR complex and does notPKC1 [6]. Consistent with this finding, the rictor-con-
co-immunoprecipitate with control proteins (Figure 1C).taining mTOR complex contains GL but not raptor
Leucine levels and mitochondrial inhibition with anti-and it neither regulates the mTOR effector S6K1 nor
mycin regulate the activity of S6K1 and 4E-BP1 [1, 8–10]is it bound by FKBP12-rapamycin. We find that the
as well as the stability of the raptor-mTOR interactionrictor-mTOR complex modulates the phosphorylation
[1], but these conditions do not affect the mTOR-rictorof Protein Kinase C  (PKC) and the actin cytoskele-
interaction (Figure 1C). Similarly, under the appropriateton, suggesting that this aspect of TOR signaling is
cell lysis conditions, rapamycin treatment of cells elimi-conserved between yeast and mammals.
nates the binding of mTOR to raptor [1] without affecting
the interaction of rictor with mTOR (Figure 1C). Like
Results and Discussion raptor but not the control hGCP3 (human -tubulin com-
ponent protein 3), recombinant myc-rictor enters the
To identify novel components of the mTOR signaling endogenous mTOR complex and can be used to isolate
complex, we purified mTOR with methods that preserve endogenous mTOR (Figure 1D). The interaction between
the raptor-mTOR interaction [1]. We had previously no- recombinant rictor and mTOR has similar detergent sen-
ticed that the mTOR complex immunopurified from sitivities as that between the endogenous proteins (Fig-
HEK293T cells contains a low-abundance 200 kDa pro- ure 1D).
tein (data not shown), but only when purified from HeLa Raptor and mTOR are in a nearly stoichiometric ratio
cells did the complex contain enough of this protein (0.8–0.9 raptor to 1.0 of mTOR) in mTOR complexes in
for its identification (Figure 1A). Like the raptor-mTOR HEK293T cells [1]. During the purification of rictor, it
interaction, the p200-mTOR interaction is sensitive to was apparent that in HeLa cells this is not true and
Triton X-100 but stable in CHAPS-containing buffers that complexes in these cells have less raptor but more
(Figure 1A). rictor. When comparing mTOR complexes across mam-
malian cell types, we observe an inverse correlation
between the relative amounts of raptor and rictor (Figure*Correspondence: sabatini@wi.mit.edu
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Figure 1. Rictor Is a Novel mTOR-Associated Protein
(A) Silver stain of SDS-PAGE analysis of mTOR immunoprecipitates prepared from HeLa cells lysed in a CHAPS- or Triton X-100-containing
buffer. Plus sign indicates inclusion of the blocking peptide for the mTOR antibody during the immunoprecipitation. The 200 kDa band
corresponds to rictor and a nonspecific band (NS) obscures raptor.
(B) Putative rictor homologs share common domain architectures. Indicated proteins have seven domains with sequence conservation and
similar relative locations within each protein and are shown schematically as boxes. Domain five is repeated four times within each of the
homologs and the multiple sequence alignment shows the sequence pattern of this repeat. Sequences with the following accession numbers
were used to create the alignment: D. melanogaster, AAQ22398.1; A. gambiae, XP_309233.1; H. sapiens, AY515854; D. discoidieum,
AAC35553.1; S. pombe, NP_596021.1; S. cerevisiae; NP_011018.1.
(C) Specific interaction between endogenous mTOR and rictor. Immunoprecipitates prepared from HEK293T cells with the indicated antibodies
were analyzed by immunoblotting for mTOR, rictor, and raptor. Prior to use, cells were treated with 5 M Antimycin A for 15 min (Antimy), 20
nM rapamycin for 15 min (Rapa), deprived of leucine for 90 min (Leu), or deprived of leucine and stimulated with 52 g/ml leucine for 10
min (LeuLeu). Immunoblots for phospho-T389 S6K1 and S6K1 show that cell treatments had the intended effects. Abbreviations: EGFR,
epidermal growth factor receptor; ATM, ataxia telangiectasia mutated.
(D) Endogenous mTOR interacts with recombinant rictor and raptor. Cellular lysates and mTOR immunoprecipitates prepared from HEK293T
cells expressing myc-rictor, myc-raptor, or myc-GCP3 were analyzed by immunoblotting for myc-tagged proteins. In parallel, anti-myc
immunoprecipitates were analyzed by immunoblotting for mTOR.
2A and data not shown). Although mTOR complexes in associates with raptor, rictor, and GL in a detergent-
sensitive manner (Figure 2B). In contrast, complexesHeLa, HEK293T, and DU145 cells contain about the
same amount of mTOR, those in HeLa and DU145 cells isolated with the raptor antibody contain mTOR and
GL but not rictor, while those isolated with the rictorhave more rictor than those in HEK293T cells. The oppo-
site is true for raptor, as mTOR complexes in HEK293T antibody contain mTOR and GL but not raptor (Figure
2B). Thus, raptor and rictor independently associate withcells have more raptor than complexes in HeLa and
DU145 cells (Figure 2A). Budding yeast has two distinct mTOR and GL and define two distinct mTOR com-
plexes. Consistent with this, the expression of wild-typeTOR complexes defined by proteins with similarity to
raptor and rictor [6, 7]. To determine if this is true in raptor, but not of a mutant that cannot bind mTOR [1],
suppresses the interaction of co-expressed rictor withmammalian cells, we isolated mTOR complexes using
antibodies recognizing mTOR, raptor, or rictor and then mTOR (Figure 2C).
As rapamycin does not affect the interaction betweendetermined the composition of the isolated complexes.
As expected, mTOR isolated with the mTOR antibody rictor and mTOR (Figure 1C) and in yeast the AVO3p-
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Figure 2. Rictor and Raptor Define Two Dis-
tinct mTOR-Containing Complexes
(A) Immunoblot analyses for indicated pro-
teins of mTOR immunoprecipitates and cell
lysates prepared from HeLa, HEK293T, and
DU145 cells. Equal amounts of total protein
were analyzed from each cell type.
(B) Immunoblot analyses for the presence of
the indicated components of the mTOR sig-
naling complex in immunoprecipitates pre-
pared from HEK293T cell lysates with anti-
bodies against rictor, mTOR, or raptor.
(C) Recombinant wild-type raptor, but not a
mutant raptor, suppresses the binding of ric-
tor to mTOR. mTOR immunoprecipitates pre-
pared from HEK293T cells expressing the in-
dicated tagged proteins were analyzed by
immunoblotting with anti-myc and anti-HA
antibodies.
containing TOR complex is rapamycin insensitive [6], tor-containing mTOR complexes—isolated with antibod-
ies recognizing mTOR or raptor—phosphorylate S6K1 inwe asked if the rictor-mTOR complex interacts with
FKBP12-rapamycin. Our previous work shows that a rapamycin-sensitive fashion. A potential explanation
for the inability of the rictor-mTOR complex to phosphor-FKBP12-rapamycin destabilizes the raptor-mTOR inter-
action so that no raptor remains bound to mTOR [1]. As ylate S6K1 might be that when bound to rictor, mTOR
is inactive. This is unlikely because mTOR still appears toothers have not observed this [3, 6], we suspected that
a component of our buffer system might be critical for autophosphorylate in rictor-containing complexes from
HeLa or HEK293T cells (see arrows in Figure 3E) andthe destabilizing effect of rapamycin on the mTOR-rap-
tor interaction. This turns out to be the case—we find the rictor complex phosphorylates the nonphysiological
substrate myelin basic protein (data not shown). In ki-that for rapamycin to affect the interaction, the cell lysis
buffer must contain a molecule with a phosphate group nase assays, a protein of the same apparent molecular
weight as rictor becomes phosphorylated (see arrows(sodium pyrophosphate and -glycerophosphate in our
buffer) (Figure 3A). Using a phosphate-free buffer, we in Figure 3E), suggesting that rictor may be a substrate
for mTOR. This may be true because in cells metaboli-were able to show that in the presence of rapamycin,
HA-FKBP12 expressed in HEK293T cells binds to the cally labeled with radioactive phosphate, a reduction in
mTOR expression decreases the amount of radioactivityraptor- but not the rictor-containing mTOR complexes
(Figure 3B). Thus, rictor, analogous to yeast AVO3p, is in rictor without affecting its expression (Supplemental
Figure S1A at http://www.current-biology.com/cgi/content/unlikely to participate in rapamycin-sensitive functions
of mammalian TOR. full/14/14/1296/DC1). In cells with reduced mTOR ex-
pression, rictor appears as a doublet in SDS-PAGE anal-To confirm this, we determined whether rictor regu-
lates S6 Kinase 1 (S6K1), a controller of cell size and an yses, suggesting that dephosphorylated rictor migrates
more quickly than the phosphorylated protein (Supple-mTOR substrate [11, 12] whose phosphorylation state
is rapamycin sensitive [13, 14]. Unlike reductions in rap- mental Figure S1B), a result we confirmed using in vitro
phosphatase treatment of immunoprecipitated rictortor or mTOR expression [1], an siRNA-mediated knock-
down of rictor does not decrease the phosphorylation (Supplemental Figure S1C). Using this shift in rictor mi-
gration, we searched for conditions that affect rictorof S6K1 in HEK293T or HeLa cells (Figure 3C). In contrast,
we observe a slight increase in phospho-S6K1 that corre- phosphorylation within cells. Treatment of cells with
LY294002, a PI 3-Kinase and mTOR kinase inhibitor [15],lates with a small increase in the amount of raptor in
mTOR complexes from cells with reduced rictor expres- increased rictor mobility while rapamycin had no effect.
Of many different stress conditions tested, only a sorbi-sion. Similarly, in Drosophila S2 cells, dsRNA-induced
RNAi against dS6K, dTOR, or dRaptor eliminates the tol-induced osmotic stress increased rictor mobility
(Supplemental Figure S1D).phosphorylation of dS6K while a dsRNA targeting dRic-
tor causes an increase in dS6K phosphorylation (Figure Only recently are we beginning to understand the bio-
chemical composition and regulation of the raptor-con-3D). As might be expected, the activation of S6K caused
by reductions in rictor levels leads to a small increase taining mTOR complex that is the target of rapamycin.
Even before its characterization, many molecular (e.g.,in the mean sizes of human and Drosophila cells (data
not shown). Thus, rictor is a positive regulator neither S6K1 phosphorylation) and cellular (e.g., cell size control)
functions were ascribed to it because of their sensitivityof cell size nor of S6K phosphorylation, and intracellu-
larly the composition of the mTOR complex is dynamic to rapamycin. The rictor-containing mTOR complex does
not appear to participate in rapamycin-sensitive pro-so that decreases in rictor levels lead to increases in
the amount of the raptor-containing mTOR complex. cesses and for us, an important insight into a function
for rictor began with a fortuitous observation. In immu-Consistent with these findings, rictor-containing mTOR
complexes purified from HEK293T or HeLa cells do not noblots prepared from cells with reduced rictor expres-
sion, we noticed a decrease in the intensity of a faintphosphorylate S6K1 in vitro (Figure 3E). In contrast, rap-
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the cross-reacting protein could be one of the Protein
Kinase C (PKC) isoforms that are known to have phos-
phorylation sites homologous to T389 of S6K1. Using
phosphospecific antibodies, we discovered that a re-
duction in rictor expression decreases the phosphoryla-
tion of S657 of PKC (Figure 4A) but not of homologous
sites in PKC and PKC (Supplemental Figure S2B). The
band recognized in immunoblots by the S657 PKC
phosphospecific antibody represents PKC because
siRNAs targeting PKC reduces its intensity (Supple-
mental Figure S2C). That rictor expression affects PKC
phosphorylation was particularly interesting because in
yeast, the rapamycin-insensitive TOR complex signals
through PKC1 to regulate the actin cytoskeleton [6],
although the role of PKC1 phosphorylation is unknown.
Using lentiviral-mediated expression of siRNAs [16], we
generated a set of HeLa cell lines with substantially
reduced levels of rictor, raptor, or mTOR (Figure 4A).
As expected, reductions in raptor or mTOR expression
decreased the phosphorylation of S6K1 and a known
substrate, eEF2K [17]. On the other hand, a reduction
in rictor expression slightly increased S6K1 and eEF2K
phosphorylation while, like a reduction in mTOR expres-
sion, decreasing PKC phosphorylation. Neither rapa-
mycin treatment nor a decrease in raptor expression
affected the phosphorylation of PKC (Figure 4A). PKC
has less kinase activity in the rictor and mTOR knock-
down cells (Figure 4B), consistent with the importance
of S657 phosphorylation for PKC kinase activity [18].
Rictor and mTOR also regulate PKC phosphorylation
in Drosophila because dsRNAs targeting dRictor and
Figure 3. Rictor Does Not Participate in Rapamycin-Sensitive dTOR, but not dRaptor, reduced the phosphorylation of
mTOR Functions a protein with the predicted molecular weight of dPKC
(A) The sensitivity of the raptor-mTOR interaction to rapamycin de- (Figure 4C). We have not found environmental stimuli
pends on the presence of phosphate-containing molecules in the that affect S657 phosphorylation (data not shown), but
lysis buffer. mTOR immunoprecipitates prepared from cells treated the classic PKC activator, phorbol myristate acetate
with or without 20 nM rapamycin for 10 min and lysed in a phosphate-
(PMA), increases S657 phosphorylation in a manner sen-containing or phosphate-free buffer were analyzed by immunoblot-
sitive to rictor and mTOR expression (Supplemental Fig-ting for the indicated proteins.
(B) Raptor and mTOR, but not rictor, copurify with FKBP12-rapa- ure S2D).
mycin. Anti-HA immunoprecipitates prepared from HEK293T cells In mammalian cells, PKC is ubiquitously expressed
expressing HA-FKBP12 and treated with or without 20 nM rapa- and has been implicated in varied cellular processes,
mycin for 15 min were analyzed by immunoblotting for the indicated including apoptosis, growth, cell cycle control, and the
proteins.
regulation of cell shape and mobility [19]. HeLa cells(C) Suppression of rictor expression slightly increases the amount
with constitutively reduced levels of rictor do not haveof raptor in the mTOR complex and S6K1 activity. mTOR immuno-
precipitates and cell lysates prepared from HEK293T or HeLa cells apparent defects in cell proliferation, but we noticed
transfected with siRNAs targeting lamin or rictor were analyzed by that these cells are flatter and have a more square-like
immunoblotting for the indicated proteins. shape than controls (data not shown). Because in yeast
(D) Suppression of Drosophila rictor expression increases the phos- AVO3p regulates actin organization through PKC1 in a
phorylation state of dS6K. The indicated dsRNAs were applied to
rapamycin-insensitive manner [20], we reasoned that anDrosophila S2 cells and cell lysates were analyzed by immunoblot-
altered actin cytoskeleton might account for the per-ting with the mammalian phosphospecific S6K1 and Drosophila S6K
antibodies. turbed morphology of the rictor knockdown cells. In
(E) The rictor-containing mTOR complex does not phosphorylate control cells and the smaller raptor knockdown cells,
S6K1. Immunoprecipitates prepared with the indicated antibodies actin localizes to the cell cortex as well as diffusely
were used in mTOR kinase assays using S6K1 as a substrate [1]. throughout the cell cytoplasm (Figures 4D and 4E). In
Where indicated, immunoprecipitates were treated with 100 nM
contrast, in rictor knockdown cells, thick actin fibers areFKBP12-rapamycin for 40 min before the start of the assays. Immu-
present throughout much of the cytoplasm and corticalnoblotting was used to monitor the levels of rictor, mTOR, and raptor
actin is less prominent. Many cells have cytoplasmicin the kinase reactions.
bundles of thick actin fibers that look like stress fibers
and do not have clear connections to the remainder of
background band recognized by the phospho-T389 the actin cytoskeleton (arrow in Figure 4D, rictor actin
S6K1 antibody (Supplemental Figure S2A). We reasoned panel). In cells with reduced mTOR expression, the pat-
that the antibody was cross-reacting with a protein con- tern of the actin staining is similar to that in rictor knock-
down cells (arrow in Figure 4D, mTOR actin panel), al-taining a similar phosphorylation site, so we asked if
Current Biology
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Figure 4. Rictor and mTOR, but not Raptor, Regulate the PKC Phosphorylation State and the Actin Cytoskeleton
(A) Immunoblotting was used to analyze the phosphorylation states of PKC (S657), S6K1 (T389), and eEF2K (S366) in HeLa cells with reduced
expression of rictor, raptor, or mTOR. Lentiviruses were used to express siRNAs targeting rictor, raptor, mTOR, or luciferase.
(B) Kinase activity of PKC isolated from samples like those in (A). Assay was performed in triplicate and activity was normalized to the
luciferase (lucif.) control.
(C) dsRNAs corresponding to the genes for the indicated proteins were transfected into S2 Drosophila cells. After 4 days, lysates were
prepared and analyzed by immunoblotting for dPKC and phospho-dPKC levels.
(D) Staining for actin (red), paxillin (green), and DNA (blue) reveals the organization of the actin cytoskeleton in HeLa cells infected with the
siRNA-expressing lentiviruses described in (A). Arrows point to bundles of actin fibers. Images captured with a 60 objective are shown.
(E) Higher magnification of portions of the merged images from (D).
though more difficult to appreciate because of the down cells, we asked if a PKC knockdown affects the
actin cytoskeleton of HeLa cells (Supplemental Figurereduced size of mTOR knockdown cells. The localization
of paxillin, an adaptor protein present at the junction S2E). The morphology of the actin cytoskeleton in cells
with siRNA-mediated reductions in PKC is similar butbetween the actin cytoskeleton and the plasma mem-
brane [21], is also altered in the rictor and mTOR knock- not a mimic of that in the rictor knockdown cells. Both
have thick cytoplasmic actin fibers and less corticaldown cells. These cells have many cytoplasmic paxillin
patches that colocalize to the ends of the thick actin actin staining than controls, but in the PKC knockdown
cells the thick actin fibers appear more numerous, betterfibers while in the control and the raptor knockdown
cells, the paxillin patches are present mainly at the cell organized, and connected to the remainder of the cy-
toskeleton. Thus, similar to AVO3p and TOR in yeast,periphery within cellular extensions (Figures 4D and 4E).
As PKC activity is reduced in rictor and mTOR knock- our findings indicate that rictor and mTOR regulate the
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